SCHEMBL4755679

SCHEMBL4755679

CCCCCCCCCCCCCCCCCC(=O)C(C)(CN(C)C)C(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 8/20 0.52
▸ CES1 P23141 8/20 0.52
▸ CES2 O00748 5/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ PPARG P37231 5/20 0.43
▸ PPARD Q03181 5/20 0.43
▸ PPARA Q07869 5/20 0.43
▸ HDAC11 Q96DB2 4/20 0.43
▸ TSHR P16473 3/20 0.43
▸ GPR84 Q9NQS5 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TLR2 O60603 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ FABP4 P15090 2/20 0.43
▸ PTPN1 P18031 2/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.43
▸ SLC22A8 Q8TCC7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4790143 1.00 FAAH (0.52) FAAHCES1CES2MEN1KMT2A
SCHEMBL7870486 1.00 FAAH (0.52) FAAHCES1CES2MEN1KMT2A
SCHEMBL724408 1.00 FAAH (0.52) FAAHCES1CES2MEN1KMT2A
SCHEMBL21980705 0.90 FAAH (0.59) FAAHCES1MEN1KMT2AHSD17B10
Trimethylammonium SCHEMBL4658910 0.82 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
Trimethylammonium SCHEMBL1711942 0.82 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
Trimethylammonium SCHEMBL3246194 0.82 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
SCHEMBL4753504 0.81 FAAH (0.44) FAAHCES1CES2MEN1KMT2A
SCHEMBL4755766 0.80 FAAH (0.43) FAAHCES1CES2MEN1KMT2A
SCHEMBL4756707 0.80 FAAH (0.43) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054532-A1 MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-09-14 — — EP claimed
WO-2021152115-A1 BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-08-05 — — WO claimed
WO-2021123399-A1 MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-06-24 — — WO claimed
EP-2654779-A1 LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF Ludwig Institute for Cancer Research, Ltd. (US) 2013-10-30 — — EP claimed
WO-2012088414-A1 LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) 2012-06-28 — — WO claimed
EP-1100464-A1 LIPID EMULSION AND SOLID LIPID NANOPARTICLE AS A GENE OR DRUG CARRIER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2001-05-23 — — EP claimed
WO-2000006120-A1 LIPID EMULSION AND SOLID LIPID NANOPARTICLE AS A GENE OR DRUG CARRIER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-02-10 — — WO claimed
WO-2025076338-A1 NANOBUBBLES FOR ULTRASOUND MEDIATED NUCLEIC ACID DELIVERY CASE WESTERN RESERVE UNIVERSITY (US) 2025-04-10 — — WO disclosed
WO-2024105084-A1 USE OF LIPIDS CONJUGATED WITH POLY(ETHYLENE OXIDE) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS Johannes Gutenberg-Universität Mainz (DE) 2024-05-23 — — WO disclosed
WO-2023227548-A1 NUCLEOTIDE DELIVERY FROM INJECTABLE HYDROPHOBIC BIOMATERIAL DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
WO-2023227517-A1 FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
WO-2023227518-A1 POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-30 — — WO disclosed
EP-4263830-A1 MIRNA COMPOSITION COMPRISING 11 SPECIFIC MIRNAS AND ITS USE IN THE TREATMENT OF CANCER INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2023-10-25 — — EP disclosed
WO-2015117021-A1 METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY FACTOR BIOSCIENCE INC. (US) 2015-08-06 — — WO disclosed
EP-2654779-A1 LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF Ludwig Institute for Cancer Research, Ltd. (US) 2013-10-30 — — EP disclosed
WO-2012088414-A1 LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) 2012-06-28 — — WO disclosed
WO-2008155141-A2 NOVEL FACULTATIVE CATONIC STEROLS NOVOSOM AG (DE) 2008-12-24 — — WO disclosed
EP-1100464-A1 LIPID EMULSION AND SOLID LIPID NANOPARTICLE AS A GENE OR DRUG CARRIER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2001-05-23 — — EP disclosed
WO-2000006120-A1 LIPID EMULSION AND SOLID LIPID NANOPARTICLE AS A GENE OR DRUG CARRIER KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-02-10 — — WO disclosed
WO-2000000033-A1 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-01-06 — — WO disclosed
Send feedback